Lead researcher discusses psilocybin therapy trial @UWMedicineHealth
Lead researcher discusses psilocybin therapy trial  @UWMedicineHealth
Uploaded December 2024 | Updated September 2026, 2 weeks ago
Dr. Anthony Back (pronounced bock), a professor of medicine and practitioner with UW Medicine in Seattle, discusses the clinical trial of psilocybin psychotherapy whose findings were published in JAMA Network Open on Dec. 5, 2024. The participants in the trial were front-line clinicians who became burned out and depressed while treating patients early in the COVID-19 pandemic.

Related news release at UW Medicine: https://newsroom.uw.edu/news-releases/psilocybin-therapy-helps-clinicians-process-covid-despair
Lead researcher discusses psilocybin therapy trialWildfire smoke linked to higher preterm birth riskProtecting toddlers from falling out of windowsParalysis study: device returns hand functionAirlift Northwest readies for World Cup emergenciesTed (Klainer) Talks; Episode 5 Pt 2 Sommer Kleweno Walley- 28 Years at Harborview Medical CenterHow severe? Describing TBI more precisely is a goalNew hope for patients with rare eye cancersDo cold plunges boost your mood?It’s a great day for a walk! #walkingVirtual Primary CareRobotic Heart Surgery at UW Medicine: Faster Recovery, Advanced Care
UW Medicine |

Lead researcher discusses psilocybin therapy trial

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER